Fact CheckerSign in

NCT07355933Completed

Metabolic Flexibility and Metabolic Heath in Human Obesity

Metabolic Flexibility, Eating Behavior and Adipose Tissue Expandability: Role of This Triad in the Propensity to Human Obesity

Source: ClinicalTrials.gov · Last updated 27 Feb 2026

Brief summary (registry, in English)

This interventional study explores the relationship between improvements in metabolic health following weight loss and changes in whole-body fat mass and its distribution. The study focuses on adult men and women with excess body weight undergoing dietary energy restriction over 12 weeks. The primary research question is: Does a greater reduction in fat mass for a given weight loss correlate with more significant improvements in metabolic health?

Status (registry)
Completed
Study type
Interventional
Enrollment
74 (actual)
First submitted
25 Jul 2025
Start date
23 Sept 2022
Primary completion date
6 Jan 2025
Lead sponsor
Jose Galgani
Diseases
Obesity
NCT number
NCT07355933

What you commit to

  • Study type: Interventional
  • Participants enrolled: 74
  • From 23 Sept 2022 to the primary completion date, 6 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Individuals with physiological (pregnancy, lactation) or pathological (under drug therapy for and/or having cardiovascular, liver, kidney, thyroid diseases)
  • conditions affecting energy metabolism or eating behavior

Other

  • Subjects having low-fat (\<20% energy) or low-carbohydrate (\<45% energy) diets
  • Smokers and alcohol abusers

Who the study is looking for

  • males or females
  • 30-55 y old
  • physically inactive (\<600 MET´min/wk of self-reported moderate-vigorous physical activity
  • stable body weight for at least the past 6 months (±2 kg)
  • healthy according to medical history and routine hematology and biochemistry.

Age in the registry: 30 years to 55 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Avda. Libertador Bernardo O´Higgins 340. Santiago. Chile.
Coordinator of this site? Confirm its status
SantiagoChileUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.